Skip to main content
. 2020 May 15;20(3):217–223. doi: 10.1007/s40268-020-00308-1

Fig. 2.

Fig. 2

Concentration of edoxaban in the six samples of human plasma (two samples) and bovine serum albumin (BSA) solution (four samples) as measured by liquid chromatography-tandem mass spectrometry before (baseline concentration) and after sorbent adsorption (adsorbed concentration) (a); average concentration of edoxaban in human plasma before and after sorbent adsorption (b)